Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06540183

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy in Children

Conditions: Hypertrophic Cardiomyopathy, Obstructive

Sex: All

Ages: N/A – 18 Years

Healthy volunteers: No

Enrollment: 23

Sponsor: Xijing Hospital

Location: Xijing Hospital Xi'an Shaanxi

Summary

The primary purpose of this study was to demonstrate the safety and efficacy of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) in children and assessed its performance and functional outcomes in the follow-up. This is a single-arm, single-center study.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of hypertrophic obstructive cardiomyopathy * Age younger than 18 years * Resting or provoking left ventricular outflow tract gradient ≥ 50 mmHg * Drug-refractory symptoms or intolerable to pharmaceutical therapies * Heart function of New York Heart Association ≥ class II Exclusion Criteria: * Secondary left ventricular hypertrophy (LVH) related to subaortic stenosis or aortic stenosis * Presence of concomitant heart disease requiring surgery * Left ventricular ejection fraction \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06540183). StuddyBuddy aggregates publicly available trial information.